Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2023 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.00B | 1.00B | 853.11M | 944.86M | 639.97M | 460.28M |
Gross Profit | 377.18M | 433.10M | 163.28M | 280.88M | 156.60M | 122.43M |
EBITDA | 99.17M | 93.65M | 57.98M | 80.72M | 47.33M | 49.16M |
Net Income | 52.43M | 52.43M | 30.44M | 46.20M | 25.14M | 7.99M |
Balance Sheet | ||||||
Total Assets | 971.27M | 971.27M | 871.87M | 971.04M | 843.35M | 697.40M |
Cash, Cash Equivalents and Short-Term Investments | 25.29M | 25.29M | 24.73M | 18.83M | 12.52M | 2.12M |
Total Debt | 94.69M | 94.69M | 111.81M | 156.08M | 141.23M | 37.82M |
Total Liabilities | 177.03M | 177.03M | 176.25M | 229.22M | 178.16M | 94.40M |
Stockholders Equity | 794.25M | 794.25M | 695.63M | 741.82M | 665.19M | 603.00M |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 35.66M | 17.80M | -43.20M | -85.60M | -59.78M |
Operating Cash Flow | 0.00 | 217.19M | 54.48M | 118.13M | -25.05M | -37.53M |
Investing Cash Flow | 0.00 | -137.26M | -36.68M | -160.63M | -83.53M | -22.26M |
Financing Cash Flow | 0.00 | -24.19M | -9.57M | -19.66M | 108.40M | 61.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | 5.08B | 26.12 | 5.40% | 0.41% | 27.70% | 0.00% | |
65 Neutral | 1.71B | 17.50 | 4.93% | ― | 18.96% | 113.59% | |
63 Neutral | ₹3.47B | 65.75 | ― | 4.84% | 6.90% | ||
61 Neutral | 3.30B | 7.87 | 5.99% | 1.16% | 18.61% | 4.02% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
PIL Italica Lifestyle Limited has published its unaudited financial results for the quarter ending June 30, 2025. These results were approved by the board on July 29, 2025, and subsequently published in several newspapers. This disclosure is in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The publication of these financial results is an important step for stakeholders to assess the company’s financial health and performance during the specified period.